Showing results (1701-1710 of 5,261) with videos related to
Sort By:
Pageof 527
Oncology|March 1, 1997
Relationship between p53 overexpression and gastric cancer progressionJ H Kim, H D Uhm, S J Gong, et al.Oncology|May 1, 1996
Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinomaM Victorzon, P J Roberts, C Haglund, et al.Oncology|May 1, 1996
A preliminary report of neoadjuvant chemotherapy NSH-7 study in osteosarcoma: preoperative salvage chemotherapy based on clinical tumor response and the use of granulocyte colony-stimulating factorT Wada, K Isu, N Takeda, et al.Oncology|May 1, 1996
Immunohistochemistry of p53 protein in transitional-cell carcinoma of the bladder using an image analyzerH Shiina, M Igawa, H Yagi, et al.Oncology|January 28, 2006
Role of anastrozole across the breast cancer continuum: from advanced to early disease and preventionJean-Marc NabholtzOncology|January 18, 2006
Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancerGianfilippo Bertelli, Ornella Garrone, Marco Merlano, et al.Oncology|February 1, 2006
A phase II study of infusional 5-fluorouracil and low-dose leucovorin with docetaxel for advanced gastric cancerH-C Jeung, Sun Young Rha, Yong Tae Kim, et al.Oncology|January 14, 1999
Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experienceC Kollmannsberger, K Mross, A Jakob, et al.Oncology|January 14, 1999
Optimal timing (Preemptive versus supportive) of granulocyte colony-stimulating factor administration following high-dose cyclophosphamideG Koumakis, M Vassilomanolakis, V Barbounis, et al.Oncology|January 14, 1999
Increased serum concentration of circulating soluble receptor for interleukin-2 and its effect as a prognostic indicator in cachectic patients with gastric and colorectal cancerM Shibata, M TakekawaPageof 527